Showing results (201-210 of 211) with videos related to
Sort By:
Pageof 22
Lancet (London, England)|June 7, 2016
Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01)Katsuhiko Uesaka, Narikazu Boku, Akira Fukutomi, et al.Journal of Gastroenterology|April 16, 2026
Usefulness of an S-1 dosage formula for predicting adverse events in adjuvant chemotherapy for curatively resected pancreatic cancer: an exploratory analysis of the randomized clinical trial (JASPAC-01)Kazunaga Ishigaki, Yousuke Nakai, Kousuke Kashiwabara, et al.Annals of Surgical Oncology|December 26, 2025
High E2F7 Expression Indicates Pancreatic Cancer Aggressiveness and Downregulation of E2F7 Enhances Sensitivity to S-1Keizo Fujita, Yukiyasu Okamura, Masamichi Hayashi, et al.European Journal of Cancer (Oxford, England : 1990)|February 26, 2018
Health-related quality of life of adjuvant chemotherapy with S-1 versus gemcitabine for resected pancreatic cancer: Results from a randomised phase III trial (JASPAC 01)Yasuhiro Hagiwara, Yasuo Ohashi, Katsuhiko Uesaka, et al.Journal of Hepato-Biliary-Pancreatic Sciences|August 16, 2024
Outcomes of patients with initially unresectable pancreatic cancer who underwent conversion surgery after FOLFIRINOX or gemcitabine plus nab-paclitaxel chemotherapy: A multicenter retrospective cohort study (PC-CURE-1)Naohiro Okano, Manabu Kawai, Makoto Ueno, et al.Cancer Reports (Hoboken, N.J.)|July 30, 2021
Concordance of human equilibrative nucleoside transporter-1 expressions between murine (10D7G2) and rabbit (SP120) antibodies and association with clinical outcomes of adjuvant chemotherapy for pancreatic cancer: A collaborative study from the JASPAC 01 trialYukiyasu Okamura, Narikazu Boku, Paula Ghaneh, et al.Cancer Science|November 29, 2019
Human equilibrative nucleoside transporter-1 expression is a predictor in patients with resected pancreatic cancer treated with adjuvant S-1 chemotherapyYukiyasu Okamura, Satoru Yasukawa, Hiroto Narimatsu, et al.Cancer Medicine|March 31, 2023
Molecular genetic positioning of small intestine and papilla of Vater carcinomas including clinicopathological classificationMasanori Nakamura, Yukiyasu Okamura, Keiichi Ohshima, et al.Journal of Gastroenterology|September 6, 2025
Combination chemotherapy for older patients with unresectable biliary tract cancer: a prospective observational study using propensity-score matched analysis (JON2104-B)Satoshi Kobayashi, Kohei Nakachi, Kouji Yamamoto, et al.Cancers|June 10, 2022
An International Retrospective Observational Study of Liver Functional Deterioration after Repeat Liver Resection for Patients with Hepatocellular CarcinomaZenichi Morise, Luca Aldrighetti, Giulio Belli, et al.Pageof 22